Mombo News Mombo News

Today's Subscriber Highlights

Every day, our subscribers receive personalized newsletters on the topics that matter to them. Here's a sample of what landed in inboxes today.

Updated August 27, 2026

Retro Biosciences Tests RTR 242 Autophagy-Inducer for Alzheimer's and Dementia Prevention

Retro Biosciences, the longevity startup funded by Sam Altman, is advancing clinical trials in Australia for its lead compound RTR 242. The pill is designed to stimulate cellular recycling processes that typically decline with age, specifically targeting the protein aggregation seen in neurodegenerative diseases like Alzheimer's and Parkinson's. CEO Joe Betts-LaCroix reported that current cohorts have shown no major safety signals, prompting the company to add new cohorts to identify the optimal dose for potency without side effects.

Sources: Sam Altman's Retro Biotech Testing Higher Doses of Alzheimer's Drug - Business Insider
See this edition → ... Want stories like this daily? Create your own →

NVIDIA Exceeds Estimates with $96.2 Billion Revenue Fueled by AI Buildout

NVIDIA reported fiscal second-quarter 2027 revenue of $96.2 billion, representing a 106% year-over-year increase driven by record Data Center sales of $89 billion. The company unveiled the Vera Rubin platform and Vera CPUs for AI agents, which are now in full production and shipping to partners like Microsoft Azure and Google Cloud. For the third quarter, NVIDIA provided revenue guidance of $108 billion, assuming zero Data Center compute revenue from China due to export restrictions.

Sources: NVIDIA Posts $96.2B Quarter as Data Center Revenue Hits $89B – Unite.AI
See this edition → ... Want stories like this daily? Create your own →

Neurostellar Launches Orbit Headband for Real-Time Cognitive Endurance Tracking

Chennai-based startup Neurostellar has introduced Orbit, a $250 smart headband that uses EEG and PPG sensors to monitor brain waves, heart rate, and breathing patterns. Developed with scientists from NIMHANS, the device uses proprietary algorithms to calculate 'cognitive endurance,' a metric currently used by World Chess Champion Gukesh and other top athletes to sustain focus. The device is now available for pre-order and includes a companion app with specific modules for problem-solving and deep work coaching.

Sources: How Chennai’s Neurostellar is measuring the mental stamina of Chess players - The HinduBusinessLine
See this edition → ... Want stories like this daily? Create your own →

These are just 3 of hundreds of possible topics.

You choose the topics. We find the stories. Create a newsletter that's 100% yours.

Start Your Free Trial

No credit card required.